National Pension Service Increases Stock Holdings in Cencora, Inc. $COR

National Pension Service lifted its position in Cencora, Inc. (NYSE:CORFree Report) by 6.3% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 720,381 shares of the company’s stock after purchasing an additional 42,652 shares during the quarter. National Pension Service’s holdings in Cencora were worth $243,309,000 at the end of the most recent reporting period.

Other hedge funds have also recently modified their holdings of the company. Mirae Asset Global Investments Co. Ltd. grew its holdings in shares of Cencora by 13.0% in the third quarter. Mirae Asset Global Investments Co. Ltd. now owns 48,270 shares of the company’s stock valued at $15,086,000 after purchasing an additional 5,543 shares during the period. AustralianSuper Pty Ltd purchased a new stake in shares of Cencora in the third quarter valued at about $26,191,000. Mediolanum International Funds Ltd grew its holdings in shares of Cencora by 133.0% in the third quarter. Mediolanum International Funds Ltd now owns 56,293 shares of the company’s stock valued at $17,342,000 after purchasing an additional 32,138 shares during the period. Chilton Investment Co. Inc. purchased a new stake in shares of Cencora in the third quarter valued at about $459,000. Finally, Lansforsakringar Fondforvaltning AB publ grew its holdings in shares of Cencora by 5.4% in the third quarter. Lansforsakringar Fondforvaltning AB publ now owns 60,254 shares of the company’s stock valued at $18,831,000 after purchasing an additional 3,073 shares during the period. Hedge funds and other institutional investors own 97.52% of the company’s stock.

Analyst Upgrades and Downgrades

A number of brokerages recently issued reports on COR. Weiss Ratings lowered shares of Cencora from a “buy (b)” rating to a “buy (b-)” rating in a report on Friday, May 22nd. Wells Fargo & Company decreased their target price on shares of Cencora from $429.00 to $331.00 and set an “overweight” rating on the stock in a research report on Monday, May 11th. UBS Group upped their target price on shares of Cencora from $410.00 to $412.00 and gave the company a “buy” rating in a research report on Thursday, May 7th. William Blair began coverage on shares of Cencora in a research report on Tuesday, April 28th. They issued a “market perform” rating on the stock. Finally, Barclays upped their target price on shares of Cencora from $400.00 to $425.00 and gave the company an “overweight” rating in a research report on Friday, February 13th. Twelve investment analysts have rated the stock with a Buy rating and three have given a Hold rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $380.25.

Read Our Latest Stock Analysis on COR

Cencora Stock Up 0.6%

Shares of COR opened at $269.21 on Friday. The stock has a market capitalization of $52.38 billion, a PE ratio of 20.65, a P/E/G ratio of 1.23 and a beta of 0.64. Cencora, Inc. has a 1 year low of $244.82 and a 1 year high of $377.54. The company has a debt-to-equity ratio of 3.40, a quick ratio of 0.59 and a current ratio of 0.95. The company’s 50-day simple moving average is $298.56 and its 200-day simple moving average is $333.91.

Cencora (NYSE:CORGet Free Report) last issued its quarterly earnings results on Wednesday, May 6th. The company reported $4.75 earnings per share (EPS) for the quarter, missing the consensus estimate of $4.82 by ($0.07). The business had revenue of $78.36 billion for the quarter, compared to analyst estimates of $81.09 billion. Cencora had a return on equity of 135.20% and a net margin of 0.78%.The firm’s revenue for the quarter was up 3.9% compared to the same quarter last year. During the same period in the prior year, the company posted $4.42 EPS. Cencora has set its FY 2026 guidance at 17.650-17.900 EPS. Analysts forecast that Cencora, Inc. will post 17.79 earnings per share for the current fiscal year.

Cencora Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Monday, June 1st. Stockholders of record on Friday, May 15th will be given a dividend of $0.60 per share. This represents a $2.40 annualized dividend and a dividend yield of 0.9%. The ex-dividend date of this dividend is Friday, May 15th. Cencora’s dividend payout ratio is currently 18.40%.

Cencora announced that its Board of Directors has initiated a stock buyback program on Thursday, May 21st that allows the company to buyback $2.00 billion in outstanding shares. This buyback authorization allows the company to buy up to 3.9% of its shares through open market purchases. Shares buyback programs are typically a sign that the company’s board believes its shares are undervalued.

Cencora Company Profile

(Free Report)

Cencora (NYSE:COR) is a global healthcare services and pharmaceutical distribution company that provides end-to-end solutions across the pharmaceutical supply chain. The company’s core activities include wholesale drug distribution, specialty drug distribution, and the operation of specialty pharmacies, complemented by logistics, cold-chain management and other fulfillment services designed to support complex and temperature-sensitive therapies.

Beyond physical distribution, Cencora offers a range of commercial and patient-focused services for pharmaceutical manufacturers and healthcare providers.

See Also

Want to see what other hedge funds are holding COR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cencora, Inc. (NYSE:CORFree Report).

Institutional Ownership by Quarter for Cencora (NYSE:COR)

Receive News & Ratings for Cencora Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cencora and related companies with MarketBeat.com's FREE daily email newsletter.